| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |